IL15 and interstitial lung disease: Patients with RP‐ILD show elevated levels of IL‐15, IL‐1RA, CXCL10, VCAM‐1 and ferritin, further supporting the role of systemic inflammatory markers in reflecting disease progression and outcomes.34